Fueled By The Rise Of Chronic Diseases: Transformative Forces Shaping the Biotechnology Instruments Market Landscape in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Biotechnology Instruments Industry Market Size Be by 2025?
The market size of biotechnology instruments has seen substantial growth in the past few years. This market is projected to expand from $75.64 billion in 2024 to $80.9 billion in 2025, with a compound annual growth rate (CAGR) of 7.0%. Factors contributing to the growth experienced in the historical period include an increase in complications from chronic diseases, a rising emphasis on digital solutions, a growing elderly population, a surge in demand for reverse transcription polymerase chain reaction (RT-PCR) tests, and an escalation in miniaturization.

What's the Long-Term Growth Forecast for the Biotechnology Instruments Market Size Through 2029?
Strong expansion is predicted for the biotechnology instruments market size over the coming years, with projections estimating growth to $104.52 billion by 2029, informed by a compound annual growth rate (CAGR) of 6.6%. This anticipated growth over the forecast period can be traced back to expanding biotechnology research, escalating healthcare costs and lost productivity, as well as the rising usage of medical lasers. Other contributing factors include the increasing necessity for the creation of vaccines, drugs, therapies, and diagnostic tools, as well as the growing incidence of target ailments. Key trends emerging over the forecast period are technological progress, groundbreaking developments, advances in the biotech industry, the incorporation of artificial intelligence and machine learning, and progression in genomics and proteomics fields.

View the full report here:
https://www.thebusinessresearchcompany.com/report/biotechnology-instruments-global-market-report

What Are the Key Growth Drivers Fueling the Biotechnology Instruments Market Expansion?
The surge in chronic illnesses is anticipated to fuel the biotechnology instruments market's expansion. Chronic illnesses, alternatively referred to as chronic conditions or disorders, are health-related complications that endure over a substantial period, commonly three months or more. These chronic conditions are attributable to detrimental lifestyle habits, an elderly populace, and amplified consciousness and diagnosis. Biotechnology instruments play a crucial role in enhancing patients' quality of life suffering from such chronic conditions by improving diagnostic precision, perfecting treatments, and facilitating superior disease administration. These instruments assist in pinpointing potential drug candidates and comprehending their impact on chronic illnesses. For example, in January 2023, as per the figures from the National Center for Biotechnology Information, a U.S. intergovernmental agency, there were as many as 1,958,310 fresh cancer instances in the U.S. and 609,820 instances of cancer-related fatalities in 2023. Additionally, according to the National Library of Medicine, a U.S.-based medical library, in May 2021, the worldwide cancer load is projected to reach 28.4 million cases by 2040, indicating a 47% increase from 2020. Therefore, the rising necessity for treatment of chronic diseases is propelling the growth of the biotechnology instruments market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19338&type=smp

What Are the Key Trends Driving Biotechnology Instruments Market Growth?
Leading corporations in the biotechnology instruments sector are concentrating on the creation of cutting-edge products like single-cell multi-omics items. These products aim to improve personalized medical methods and further genomics, proteomics, and metabolomics research. Single-cell multi-omics items are hi-tech methods that examine various biological data from single cells and merge information from several omics strata, such as genomics, transcriptomics, proteomics, and metabolomics. For example, in June 2023, Singleron Biotechnologies, a biotech firm from Germany, introduced two progressive instruments named NEO and Python Junior. These instruments aim to improve the standardization process of single-cell analysis workflows. The NEO system can manage up to half a million cells in a single run on four separate channels, ensuring high throughput and versatile handling of different applications simultaneously. On the other hand, the Python Junior focuses on dividing solid tissues into excellent quality single-cell suspensions, merging mechanical treatment and enzymatic digestion to improve the efficiency of the dissociation procedure.

How Is the Biotechnology Instruments Market Segmented?
The biotechnology instrumentsmarket covered in this report is segmented -

1) By Product: Lab Automation Instruments, Life Science Consumables, In Vitro Diagnostic (IVD) Instruments
2) By Application: Clinical Diagnostics, Drug Discovery And Development, Proteomics And genomics, Cell Analysis, Other Applications
3) By End-user: Pharmaceutical And Biotechnology Companies, Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Other End Users

Subsegments:
1) By Lab Automation Instruments: Robotic Liquid Handlers, Automated Plate Readers, Automated Workstations, Lab Sample Storage Systems
2) By Life Science Consumables: Reagents And Chemicals, Sample Collection And Transport Devices, Laboratory Plasticware, Culture Media And Kits
3) By In Vitro Diagnostic (IVD) Instruments: Molecular Diagnostic Instruments, Clinical Chemistry Analyzers, Hematology Analyzers, Immunoassay Analyzers

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19338&type=smp

Which Companies Are Leading the Charge in Biotechnology Instruments Market Innovation?
Major companies operating in the biotechnology instruments market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Merck KGaA, Quest Diagnostics Inc., Avantor Inc., Agilent Technologies, Illumina Inc., Sartorius AG, Mettler Toledo, Perkin Elmer Inc., Shimadzu Corporation, Bruker Corporation, Zeiss Group, QIAGEN N.V., Novanta Inc., Cynosure LLC, Bio-Rad Laboratories Inc., Ori Biotech Limited, Hudson Robotics

Which Regions Are Leading the Global Biotechnology Instruments Market in Revenue?
North America was the largest region in the biotechnology instruments market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biotechnology instruments market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19338

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.